-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Gout is the most common inflammatory arthritis worldwide, affecting up to 4% of adults, and while gout alone poses a significant burden, it is also strongly associated with comorbidities and increased mortality
.
Cardiovascular disease, hypertension, chronic kidney disease (CKD), and diabetes all account for a large proportion of gout patients.
Gout is the most common inflammatory arthritis worldwide, affecting up to 4% of adults, and while gout alone poses a significant burden, it is also strongly associated with comorbidities and increased mortality
Ted R.
Mikuls and others published a research article in JAMA Network Open ,
This study used a multivariate Cox proportional hazards regression model to examine the association of gout with LEA
.
In an analysis limited to gout patients, the attributes of serum uric acid control and uric acid-lowering therapy were examined as factors associated with LEA
This cohort study included 5,924,918 patients, of whom 556,521 had gout (mean [SD] age, 67 [12] years; 550,963 males (99.
0%)) and 5,368,397 subjects without gout (mean [SD] age, 67 [12] years old; 5,314,344 men [99.
0%])
.
Risk of lower extremity amputation in gout patients versus gout-free controls
Risk of lower extremity amputation in gout patients versus gout-free controlsCompared with subjects without gout, patients with gout were more likely to have amputations, and the ratio remained increased after adjustment ( adjusted hazard ratio, 1.
20; 95% CI, 1.
16-1.
24), and was highest among patients with below-knee amputation (adjusted hazard ratio, 1.
59; 95 % confidence interval, 1.
39 - -1.
81)
.
highest among amputees
Cumulative incidence of lower extremity amputation (LEA)
Cumulative incidence of lower extremity amputation (LEA)In gout patients, poor control of serum uric acid (mean 7 mg/dL in the previous year) was associated with a 25% to 37% increase in amputation rates
.
Conversely, urate-lowering therapy was not associated with LEA incidence
In gout patients, poor control of serum uric acid (mean 7 mg/dL in the previous year) was associated with a 25% to 37% increase in amputation rates
People with gout are more likely to develop LEA
original source
Mikuls TR, Soto Q, Petro A, et al.
Mikuls TR, Soto Q, Petro A, et al.
Comparison of Rates of Lower Extremity Amputation in Patients With and Without Gout in the US Department of Veterans Affairs Health System.
JAMA Netw Open.
Leave a Comment